Regulation of cellular oxidative stress and apoptosis by G protein-coupled receptor kinase-2; The role of NADPH oxidase 4.
暂无分享,去创建一个
A. Razzaque | S. Akhter | Shahab A Akhter | Xianyao Xu | Tiju Theccanat | Jennifer L Philip | Abdur M Razzaque | Nicholas Ludmer | Jinju Li | Xianyao Xu | Nicholas Ludmer | Tiju Theccanat | Jinju Li | Jennifer L. Philip
[1] R. Lefkowitz,et al. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. , 1995, Science.
[2] W. Koch,et al. Pro-Death Signaling of GRK2 in Cardiac Myocytes after Ischemic Stress Occurs via ERK-Dependent, Hsp90-Mediated Mitochondrial Targeting , 2013 .
[3] David M. Harris,et al. Level of G protein–Coupled Receptor Kinase-2 Determines Myocardial Ischemia/Reperfusion Injury via Pro- and Anti-Apoptotic Mechanisms , 2010, Circulation research.
[4] R. Kitsis,et al. Cell death in the pathogenesis of heart disease: mechanisms and significance. , 2010, Annual review of physiology.
[5] H. Brunner-La Rocca,et al. NADPH oxidase-dependent oxidative stress in the failing heart: From pathogenic roles to therapeutic approach. , 2012, Free radical biology & medicine.
[6] Priyesh A. Patel,et al. Physiologic and cardiac roles of beta-arrestins. , 2009, Journal of molecular and cellular cardiology.
[7] D. Kang,et al. Mitochondrial DNA Damage and Dysfunction Associated With Oxidative Stress in Failing Hearts After Myocardial Infarction , 2001, Circulation research.
[8] R. Lefkowitz,et al. Structure and mechanism of the G protein-coupled receptor kinases. , 1993, The Journal of biological chemistry.
[9] D. Sawyer,et al. Adrenergic regulation of myocardial apoptosis. , 2000, Cardiovascular research.
[10] G. Andersen,et al. Myocardial distribution and regulation of GRK and beta-arrestin isoforms in congestive heart failure in rats. , 2001, American journal of physiology. Heart and circulatory physiology.
[11] W. Koch,et al. Myocardial Adeno-Associated Virus Serotype 6–&bgr;ARKct Gene Therapy Improves Cardiac Function and Normalizes the Neurohormonal Axis in Chronic Heart Failure , 2009, Circulation.
[12] A. Shah,et al. Contrasting Roles of NADPH Oxidase Isoforms in Pressure-Overload Versus Angiotensin II–Induced Cardiac Hypertrophy , 2003, Circulation research.
[13] Xiaokun Li,et al. Activation of HIF-1 by metallothionein contributes to cardiac protection in the diabetic heart. , 2012, American journal of physiology. Heart and circulatory physiology.
[14] A. Ballestrero,et al. Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. , 2004, Journal of molecular and cellular cardiology.
[15] B. Parsons,et al. Adrenergic Effects on the Biology of the Adult Mammalian Cardiocyte , 1992, Circulation.
[16] D. Sorescu,et al. NAD(P)H Oxidase 4 Mediates Transforming Growth Factor-β1–Induced Differentiation of Cardiac Fibroblasts Into Myofibroblasts , 2005, Circulation research.
[17] P. Hašková,et al. Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity. , 2011, Free radical biology & medicine.
[18] M. Bristow. Mechanism of action of beta-blocking agents in heart failure. , 1997, The American journal of cardiology.
[19] J. Sadoshima,et al. Upregulation of Nox4 by Hypertrophic Stimuli Promotes Apoptosis and Mitochondrial Dysfunction in Cardiac Myocytes , 2010, Circulation research.
[20] Marc G. Caron,et al. Control of Myocardial Contractile Function by the Level of β-Adrenergic Receptor Kinase 1 in Gene-targeted Mice* , 1998, The Journal of Biological Chemistry.
[21] Michael D. Schneider,et al. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart , 2010, Proceedings of the National Academy of Sciences.
[22] D C Harrison,et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.
[23] B. Kobilka,et al. Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[24] S. Jamieson,et al. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. , 1986, Circulation research.
[25] D. Pimentel,et al. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. , 1998, Circulation.
[26] R. Virmani,et al. Apoptosis in myocytes in end-stage heart failure. , 1996, The New England journal of medicine.
[27] B. Kobilka,et al. Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. , 2003, The Journal of clinical investigation.
[28] Catherine Communal,et al. Opposing Effects of β1- and β2-Adrenergic Receptors on Cardiac Myocyte Apoptosis Role of a Pertussis Toxin–Sensitive G Protein , 1999 .
[29] C. McClain,et al. Angiotensin II plays a critical role in alcohol-induced cardiac nitrative damage, cell death, remodeling, and cardiomyopathy in a protein kinase C/nicotinamide adenine dinucleotide phosphate oxidase-dependent manner. , 2012, Journal of the American College of Cardiology.
[30] W. Koch,et al. Prodeath Signaling of G Protein–Coupled Receptor Kinase 2 in Cardiac Myocytes After Ischemic Stress Occurs Via Extracellular Signal–Regulated Kinase-Dependent Heat Shock Protein 90–Mediated Mitochondrial Targeting , 2013, Circulation research.
[31] H. Rockman,et al. Β-arrestin: a signaling molecule and potential therapeutic target for heart failure. , 2011, Journal of molecular and cellular cardiology.